ASKA Pharmaceutical Holdings Co.,Ltd. (TSE:4886) announces a share repurchase program. Under the program, the company will repurchase up to 300,000 shares, representing 1.05% for ¥350 million. The purpose of the program is to improve shareholder interests by implementing flexible capital policies in response to changes in the environment. The program is valid till March 31, 2022. As of end of June, 2021, the company had 28,489,599 shares (excluding treasury stock) and 2,073,600 treasury shares.